Disorders of glossopharyngeal nerve

G6_DISGLO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G52.1 Hospital discharge: ICD-9 — 3521 Hospital discharge: ICD-8 — 35602 Cause of death: ICD-10 — G52.1 Cause of death: ICD-9 — 3521 Cause of death: ICD-8 — 35602 2 out of 7 registries used, show all original rules.	65
4. Check minimum number of events None	65
5. Include endpoints None	65
6. Filter based on genotype QC (FinnGen only)	65

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G52
Name in latin: Morbositates nervi glossopharyngei

NAME	G6_DISGLO
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G521
HD_ICD_9	3521
HD_ICD_8	35602
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G521
COD_ICD_9	3521
COD_ICD_8	35602
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of glossopharyngeal nerve based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	479	287	186
Only index persons	424	266	158
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	54.76	53.17	56.97
Only index persons	53.35	52.25	55.20

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65	39	26
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	54.55	53.63	55.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
59: Matched controls
591

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G52.1

ICD-10 Finland

Disorders of glossopharyngeal nerve

+∞

72.8

N03AF01

ATC

carbamazepine; oral, rectal

27.8

18.2

G50.0

ICD-10 Finland

Trigeminal neuralgia

+∞

10.7

N03AX16

ATC

pregabalin; oral

6.1

8.6

G50.1

ICD-10 Finland

Atypical facial pain

+∞

8.5

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

3.06

3.14

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

10.67

3.03

1.0

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

5.09

2.67

1.0

1.8

0.3

0.5

ug/l

—

(3045414) Leukocytes [Presence] in Urine

4.41

2.66

1.8

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.96

2.33

1.0

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

235

2.06

2.12

12.3

6.4

1.2

mmol/l

0.88

213

(4094501)

4.29

2.09

1.2

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

113

2.11

1.88

3.5

1.9

1.0

1.4

mg/l

0.37

(3025941) Bacteria identified in Stool by Culture

2.80

1.72

1.8

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

3.77

1.64

1.4

2.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.77

1.64

1.0

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.62

1.60

1.4

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

263

1.83

1.55

11.5

6.9

1.2

mmol/l

1.14

216

(3019225) pH of Specimen

2.45

1.47

4.9

4.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

356

1.86

1.46

7.3

4.6

—

7348.4

—

(40761535) Cells panel - Urine sediment

2.38

1.44

2.3

3.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

206

1.74

1.32

2.4

1.9

81.1

88.6

pmol/l

0.63

(3023368) Bacteria identified in Blood by Culture

130

1.78

1.21

3.8

4.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

122

1.79

1.20

3.1

2.4

—

(3015736) pH of Urine

221

1.66

1.16

3.5

3.2

—

(3022313) Gas panel - Capillary blood

2.49

1.11

3.2

3.3

—

(3032080) INR in Blood by Coagulation assay

215

1.63

1.08

10.4

7.6

1.3

1.2

inr

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.37

1.05

1.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.12

1.03

36.0

13.3

96.1

94.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.00

0.97

1.3

1.7

—

(42870588) Differential panel, method unspecified - Blood

165

1.61

0.96

8.4

5.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.26

0.94

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.10

0.89

2.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

124

1.62

0.87

4.1

3.6

—

(3026008) Bacteria identified in Urine by Culture

169

1.56

0.86

3.9

3.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

110

1.60

0.78

1.6

1.7

910.5

1280.9

nmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

111

1.59

0.75

2.1

1.6

442.6

466.6

pmol/l

0.16

(3012095) Magnesium [Moles/volume] in Serum or Plasma

0.50

0.73

4.0

2.8

0.9

0.8

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.00

0.72

1.4

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1.66

0.67

2.9

2.5

—

(36660697) Celiac disease serology panel - Serum

1.78

0.65

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

142

1.48

0.64

2.7

3.0

6603.9

40.4

mg/l

0.77

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.61

0.62

32.6

10.7

108.8

122.3

g/l

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.61

0.0

2.9

—

(3042936) Bacteria identified in Isolate by Culture

1.61

0.61

3.3

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.79

0.59

36.3

9.7

26.2

26.1

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.57

0.59

1.3

1.4

—

(3019060) Gas panel - Arterial blood

1.73

0.58

5.8

5.0

—

(3044640) Blood type and Crossmatch panel - Blood

163

1.43

0.58

2.9

2.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.68

0.57

1.2

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.64

0.56

3.0

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.56

0.55

1.5

—

(3003396) Base excess in Arterial blood by calculation

1.47

0.54

28.7

9.4

1.8

mmol/l

—

(3019150) Specific gravity of Urine by Refractometry

112

1.44

0.50

4.2

4.0

—

1.0

—

(40768804) Tissue Pathology biopsy report

225

1.34

0.48

1.9

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

512

1.48

0.46

4.8

4.6

1.5

mmol/l

0.06

462

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

295

1.32

0.46

3.4

2.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.41

0.43

1.6

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

307

1.30

0.43

7.7

9.4

3.6

4.1

e9/l

0.60

265

(3002256) Pathology report gross observation

1.38

0.42

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.48

0.42

9.0

8.2

—

(3044889) 12 lead EKG panel

378

1.31

0.42

4.4

4.0

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.41

0.0

2.8

—

(3000494) Fungus identified in Specimen by Culture

1.42

0.41

1.2

1.4

—

(3013115) Eosinophils [#/volume] in Blood

261

1.28

0.38

6.8

5.9

0.2

e9/l

0.46

225

(3037467) Urinalysis macro (dipstick) panel - Urine

351

1.28

0.37

7.7

4.5

—

(3001604) Monocytes [#/volume] in Blood

252

1.27

0.37

6.7

5.8

0.5

0.6

e9/l

0.37

219

(3000991) Gas panel - Venous blood

1.43

0.36

39.3

11.0

—

(3009508) Creatinine [Moles/volume] in Urine

147

1.31

0.36

2.5

3.0

6.9

6.8

mmol/l

0.02

123

(3006315) Basophils [#/volume] in Blood

253

1.26

0.35

6.7

5.8

0.0

e9/l

0.27

219

(3003694) ABO and Rh group [Type] in Blood

141

0.74

0.34

1.9

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

197

1.26

0.32

3.4

3.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

129

0.73

0.32

5.5

4.5

18.8

22.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.33

0.31

1.7

2.6

4.9

7.5

umol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

160

0.77

0.30

3.8

3.6

—

(3019198) Lymphocytes [#/volume] in Blood

257

1.23

0.30

7.3

5.8

1.6

2.0

e9/l

0.69

224

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.25

0.27

1.4

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

182

1.23

0.26

2.3

3.0

2.3

2.4

mmol/l

0.27

161

(3023103) Potassium [Moles/volume] in Serum or Plasma

546

1.36

0.23

27.1

16.2

4.0

mmol/l

0.01

530

(40758558) Short blood count panel - Blood

123

0.78

0.23

4.9

7.0

—

(3021589) Normoblasts [#/volume] in Blood

243

1.19

0.22

7.6

9.3

0.0

e9/l

0.71

200

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

111

0.78

0.22

1.6

2.7

2.4

2.5

mmol/l

—

100

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.21

0.22

1.0

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

4.2

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

4.2

—

3.9

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

4.2

—

105.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

79.3

—

(3018095) Leukocytes [#/volume] in Urine

196

1.19

0.20

4.3

3.6

3.4

97.2

e6/l

1.24

146

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.74

0.18

1.6

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.18

0.17

1.5

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.14

0.16

3.0

1.8

9.9

13.1

umol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

554

1.23

0.15

24.7

16.7

75.4

77.6

umol/l

0.37

554

(3002385) Erythrocyte distribution width [Ratio]

440

0.87

0.15

20.5

17.5

13.8

13.9

0.28

429

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

534

1.19

0.13

22.7

13.9

24.8

22.7

mg/l

0.17

412

(3020682) Albumin/Creatinine [Ratio] in Urine

155

1.13

0.10

2.8

3.9

2.5

6.0

mg/mmol

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.18

0.10

1.6

2.4

10.0

10.6

g/l

—

(3002582) Erythrocytes [#/volume] in Urine

175

0.89

0.10

3.3

3.0

4.1

42.6

e6/l

—

133

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.15

0.09

6.0

3.9

6.2

5.7

kpa

—

(3012544) pH of Venous blood

1.15

0.09

6.0

4.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

123

0.87

0.09

6.3

4.7

—

(1761868) Lipid panel - Serum or Plasma

194

0.90

0.08

2.6

3.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.12

0.08

1.4

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.10

0.08

1.7

1.4

—

(3035941) MCH [Entitic mass]

584

0.94

0.08

31.2

20.5

30.4

0.10

574

(3026361) Erythrocytes [#/volume] in Blood

584

0.94

0.08

31.6

20.5

4.3

4.5

e12/l

0.69

565

(3007461) Platelets [#/volume] in Blood

584

0.94

0.08

31.6

20.6

254.5

246.0

e9/l

0.59

568

(3024731) MCV [Entitic volume]

584

0.94

0.08

31.3

20.5

91.5

91.3

0.10

574

(3010813) Leukocytes [#/volume] in Blood

584

0.94

0.08

31.5

20.6

7.0

6.7

e9/l

0.17

564

(3000963) Hemoglobin [Mass/volume] in Blood

584

0.94

0.08

31.6

20.7

131.8

134.7

g/l

0.75

574

(36304419) Bacteria [Presence] in Urine

157

1.11

0.08

3.5

2.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.04

0.07

3.2

1.7

—

(40761511) CBC panel - Blood by Automated count

556

1.20

0.07

17.8

13.2

—

(3013512) EKG study

162

0.90

0.07

5.1

4.4

—

(3030467) Casts [#/volume] in Urine by Automated count

162

1.07

0.02

3.3

2.8

0.0

0.4

e6/l

2.51

119

(3009542) Hematocrit [Volume Fraction] of Blood

466

0.96

0.00

24.8

15.2

38.4

39.1

0.20

327

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

156

1.03

0.00

7.2

4.9

1.3

2.7

ug/l

1.18

136

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

254

0.97

0.00

4.8

4.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.5

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.00

0.00

2.6

3.5

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.0

1.0

—

25.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

329.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

3.0

—

7.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

4.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

1.0

—

12.8

—

(3028433) Virus identified in Specimen by Culture

0.00

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.0

2.0

—

238.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

0.94

0.00

3.0

1.8

2.5

2.3

g/l

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

13.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

0.98

0.00

1.2

1.7

0.2

g/l

—

(40768797) Stomach Pathology biopsy report

0.98

0.00

1.0

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.00

0.00

2.9

1.9

14.9

21.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3045716) Anion gap in Serum or Plasma

0.00

0.0

1.2

—

8.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

220

1.00

0.00

4.4

4.0

—

(3000012) Reticulocyte production index

0.00

0.0

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.6

—

31.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

0.00

0.0

3.0

—

3.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.0

—

27.4

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_DISGLO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_DISGLO.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: G6_DISGLO – Disorders of glossopharyngeal nerve

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of glossopharyngeal nerve

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints